MAZE Overview

Company Profile

Related stocks

SNDX • United States

Syndax Pharmaceuticals, Inc.

16.99 USD

1.51B USD 1Y +2.4%

KLRA • United States

Kailera Therapeutics, Inc.

11.61 USD

1.51B USD

INVA • United States

Innoviva, Inc.

21.21 USD

1.53B USD 1Y +20.1%

RARE • United States

Ultragenyx Pharmaceutical Inc.

15.48 USD

1.53B USD 1Y -50.5%

COAG • United States

Hemab Therapeutics Holdings, In

31.62 USD

1.48B USD

RAPP • United States

Rapport Therapeutics, Inc.

30.65 USD

1.47B USD 1Y +10.3%

TSHA • United States

Taysha Gene Therapies, Inc.

4.49 USD

1.46B USD 1Y -12.5%

OMER • United States

Omeros Corporation

19.83 USD

1.44B USD 1Y +335.5%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

Region

Sector

Industry

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

3Y Volatility

Max Drawdown (3Y)

Sharpe Ratio (3Y)

Size Class

Small Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.